Why switch from warfarin to NOACs? - Wikidata - awgldk - TriplyDB

Why switch from warfarin to NOACs?

Why switch from warfarin to NOACs?

http://www.wikidata.org/entity/Q38773090

about

Dawn of the direct-acting oral anticoagulants: trends in oral anticoagulant prescribing in Wales 2009-2015.Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal.Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.

P2860

Q39078925-886DACA4-857C-48C4-98AE-9D0EE4E56EB6 Q39452481-962D26CE-8098-4B58-9E07-7C76ED9A8EC4 Q39453858-987282CA-9287-40C6-984C-AF30581C75DE

P2860

Why switch from warfarin to NOACs?

http://www.wikidata.org/entity/Q38773090

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Why switch from warfarin to NOACs?

@en

type

label

Why switch from warfarin to NOACs?

@en

prefLabel

Why switch from warfarin to NOACs?

@en

P1433

Q38773090-52190D82-274D-4452-81F5-318A2500788F

P1476

Q38773090-3DD1B139-344C-4593-AC7E-3BD4470CF101

P2093

Q38773090-2CCC4042-A3FA-4D09-8F32-10E3E41F6C40

Q38773090-34A97246-0184-4E1E-A683-C051A5B6C17B

Q38773090-9A60F71C-5969-4A5E-8F9B-76531EC683F6

Q38773090-EB0AAD9B-8B29-4D33-8EFE-A1CA58C7D193

P2860

Q38773090-0526BB61-D0CE-4BC9-AD98-55B0D6A6375D

Q38773090-0E60CF65-E89B-4C60-A9F5-4A41091717DD

Q38773090-1A48FCFA-3E8D-43EF-8EA9-718F804E7299

Q38773090-30B33536-AADE-484A-B067-4C9217C53270

Q38773090-3852DE24-168B-49D6-BF40-F115BF4CB072

Q38773090-6E77E68B-1447-4FC0-99B3-9894A0EB39A7

Q38773090-77493492-195E-4208-978A-123F3E745F80

Q38773090-90F82B76-BDC6-4063-8FE1-1684657A071C

Q38773090-A615E4B3-DC1A-4AD6-918E-45E3F1B39A70

Q38773090-AF75FA72-65B9-4D39-BA5F-37A398C1F9CA

P2888

Q38773090-110E7DC0-9CA2-4A18-9495-EC2932F93FCB

P304

Q38773090-4275CBBC-F735-46CC-975F-B5197BD092ED

P31

Q38773090-C93C4813-37F6-4448-8F05-D9D22946F16C

P356

Q38773090-BCF2F1ED-15B3-4948-BEE7-AAA2F93C43DA

P433

Q38773090-899ADA11-24E0-4087-B902-70D19DAEF584

P478

Q38773090-5BBEBB86-50CC-4A76-90D6-E3D4B9E88388

P50

Q38773090-23A885F3-5588-4E0B-A5AC-1030F62D61AD

P577

Q38773090-E34E9F2A-C8C4-40E4-9F50-D62FCFFC34C6

P698

Q38773090-217E55FF-AB7A-4F8A-93C2-B54945E6AD31

P356

S11739-016-1411-0

P1433

Internal and emergency medicine

P1476

Why switch from warfarin to NOACs?

@en

P2093

Adolfo Aita

http://www.w3.org/2001/XMLSchema#string

Claudia Bartolini

http://www.w3.org/2001/XMLSchema#string

Fabio Angeli

http://www.w3.org/2001/XMLSchema#string

Paolo Verdecchia

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Dabigatran versus warfarin in patients with atrial fibrillation

Idarucizumab for Dabigatran Reversal

Net clinical benefit of oral anticoagulants: a multiple criteria decision analysis

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

P2888

s11739-016-1411-0

P304

289-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11739-016-1411-0

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Gianpaolo Reboldi

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26972708

http://www.w3.org/2001/XMLSchema#string